news & events
portfolio news
08.07.20
VarmX raises €32 million in Series B financing to develop innovative reversal agent for the treatment and prevention of severe bleeding in patients on oral anticoagulants
07.07.20
CVRx® Raises $50 Million in New Equity Financing
29.06.20
AM-Pharma Adds Regulatory, Business Development and Legal Expertise to Leadership Team
25.06.20
SNF472 Mechanism of Action data published in British Journal of Pharmacology
16.06.20
Ona Therapeutics raises €30M in Series A financing
12.06.20
Aura Biosciences Presents Updated AU-011 Clinical Data at ARVO 2020
10.06.20
CorWave Reports Two Critical Technical Milestones Required to Proceed to the Clinical Phase at the American Society for Artificial Internal Organs Annual Meeting
01.06.20
Sanifit Enhances Leadership Team with New Executive Appointments
01.06.20
Vivet’s Second Gene Therapy Product, VTX-803 for PFIC3, Receives US and European Orphan Drug Designation
19.05.20
Galecto Appoints New Chair and Strengthens Board of Directors
